tiprankstipranks
Advertisement
Advertisement

AMRX Stock Latest News

Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
The FlyAmneal Pharmaceuticals announces FDA approval of romidepsin injection solution
3h ago
AMRX
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
PremiumThe Fly
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
3h ago
AMRX
Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays
15d ago
AMRX
Amneal Pharma Bets Big on Biosimilars in Q1 Call
PremiumCompany Announcements
Amneal Pharma Bets Big on Biosimilars in Q1 Call
15d ago
AMRX
Amneal Shareholders Back Board, Pay and Auditor at Meeting
PremiumCompany Announcements
Amneal Shareholders Back Board, Pay and Auditor at Meeting
28d ago
8K
AMRX
Amneal Pharmaceuticals reports Q1 EPS 27c, consensus 17c
PremiumThe FlyAmneal Pharmaceuticals reports Q1 EPS 27c, consensus 17c
28d ago
AMRX
Amneal Pharmaceuticals backs FY26 adjusted EPS view 95c-$1.05, consensus $1.00
Premium
The Fly
Amneal Pharmaceuticals backs FY26 adjusted EPS view 95c-$1.05, consensus $1.00
28d ago
AMRX
Amneal Pharma Bets Big On Biosimilars Growth
Premium
Company Announcements
Amneal Pharma Bets Big On Biosimilars Growth
1M ago
AMRX
Is AMRX a Buy, Before Earnings?
PremiumPre-Earnings
Is AMRX a Buy, Before Earnings?
1M ago
AMRX
Amneal to Acquire Kashiv, Expanding Biosimilars Platform
PremiumCompany Announcements
Amneal to Acquire Kashiv, Expanding Biosimilars Platform
1M ago
8K
AMRX
Amneal Pharmaceuticals raises FY26 adjusted EPS view to 95c-$1.05 from 93c-$1.03
PremiumThe Fly
Amneal Pharmaceuticals raises FY26 adjusted EPS view to 95c-$1.05 from 93c-$1.03
1M ago
AMRX
Amneal Pharmaceuticals to acquire Kashiv BioSciences
PremiumThe Fly
Amneal Pharmaceuticals to acquire Kashiv BioSciences
1M ago
AMRX
Amneal Pharmaceuticals reports Q1 adjusted EPS 27c, consensus 17c
PremiumThe FlyAmneal Pharmaceuticals reports Q1 adjusted EPS 27c, consensus 17c
1M ago
AMRX
Amneal announces additional interim Phase 4 ELEVATE-PD study results
Premium
The Fly
Amneal announces additional interim Phase 4 ELEVATE-PD study results
2M ago
AMRX
Amneal Pharmaceuticals initiated with a Buy at UBS
Premium
The Fly
Amneal Pharmaceuticals initiated with a Buy at UBS
2M ago
AMRX
Amneal announces U.S. launch of two respiratory metered-dose inhalation products
PremiumThe Fly
Amneal announces U.S. launch of two respiratory metered-dose inhalation products
2M ago
AMRX
Amneal Pharmaceuticals Earnings Call: Growth Amid Transition
PremiumCompany Announcements
Amneal Pharmaceuticals Earnings Call: Growth Amid Transition
3M ago
AMRX
Amneal Pharmaceuticals price target raised to $17 from $15 at Goldman Sachs
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $17 from $15 at Goldman Sachs
3M ago
AMRX
Amneal Pharmaceuticals price target raised to $17 from $15 at Truist
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $17 from $15 at Truist
3M ago
AMRX
Truist ups Amneal Pharmaceuticals price target, says pullback great entry point
PremiumThe FlyTruist ups Amneal Pharmaceuticals price target, says pullback great entry point
3M ago
AMRX
Amneal Pharmaceuticals: Portfolio Shift to High-Margin Brands and Biosimilars Supports Buy Rating and Upside to $17 Target
Premium
Ratings
Amneal Pharmaceuticals: Portfolio Shift to High-Margin Brands and Biosimilars Supports Buy Rating and Upside to $17 Target
3M ago
AMRX
Amneal Posts Strong Q4 Results and Raises 2026 Outlook
Premium
Company Announcements
Amneal Posts Strong Q4 Results and Raises 2026 Outlook
3M ago
8K
AMRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >